Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |